Immunization and bell's palsy in children: A case-centered analysis

American Journal of Epidemiology

Volumn 175, Issue 9, 2012, Pages 878-885

  Rowhani Rahbar, Ali ^a   Klein, Nicola P ^a   Lewis, Ned ^a   Fireman, Bruce ^a   Ray, Paula ^a   Rasgon, Barry ^a   Black, Steven ^b   Klein, Jerome O ^c   Baxter, Roger ^a  

^a KAISER PERMANENTE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bell's palsy; child; immunization; vaccines

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE;

CHILD HEALTH; DISEASE PREVALENCE; HEALTH RISK; IMMUNIZATION; INFLUENZA; POPULATION STRUCTURE; VACCINATION;

ADOLESCENT; ADULT; BELL PALSY; CHILD; DISEASE ASSOCIATION; EPIDEMIOLOGY; FAMILY HISTORY; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; IMMUNIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OTORHINOLARYNGOLOGY; REVIEW; RISK ASSESSMENT;

ADOLESCENT; BELL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; MALE;

CALIFORNIA; UNITED STATES;

HEPATITIS B VIRUS; TIPULA IRIDESCENT VIRUS;

EID: 84860647162     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws011     Document Type: Review

References (24)

1. Brandenburg NA, Annegers JF. Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982. Neuroepidemiology. 1993;12(6):313-325.
2. Katusic SK, Beard CM, Wiederholt WC, et al. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. Ann Neurol. 1986;20(5):622-627.
3. Monini S, Lazzarino AI, Iacolucci C, et al. Epidemiology of Bell's palsy in an Italian health district: incidence and casecontrol study. Acta Otorhinolaryngol Ital. 2010;30(4):198-204.
4. Rowlands S, Hooper R, Hughes R, et al. The epidemiology and treatment of Bell's palsy in the UK. Eur J Neurol. 2002;9(1): 63-67.
5. Tsai HS, Chang LY, Lu CY, et al. Epidemiology and treatment of Bell's palsy in children in northern Taiwan. J Microbiol Immunol Infect. 2009;42(4):351-356.
6. Holland NJ,Weiner GM. Recent developments in Bell's palsy. BMJ. 2004;329(7465):553-557.
7. Shargorodsky J, Lin HW, Gopen Q. Facial nerve palsy in the pediatric population. Clin Pediatr (Phila). 2010;49(5): 411-417.
8. Wilson-Pauwels L, Akesson EJ, Stewart PA. Cranial Nerves: Anatomy and Clinical Comments. Philadelphia, PA: BC Decker, Inc; 1988.
9. Lorch M, Teach SJ. Facial nerve palsy: etiology and approach to diagnosis and treatment. Pediatr Emerg Care. 2010;26(10): 763-769.
10. Adour KK, Byl FM, Hilsinger RL Jr, et al. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope. 1978;88(5):787-801.
11. Abiko Y, Ikeda M, Hondo R. Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell's palsy. Otol Neurotol. 2002;23(5):779-783.
12. Lazarini PR, Vianna MF, Alcantara MP, et al. Herpes simplex virus in the saliva of peripheral Bell's palsy patients. Braz J Otorhinolaryngol. 2006;72(1):7-11.
13. Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1):27-30.
14. Paolino E, Granieri E, Tola MR, et al. Predisposing factors in Bell's palsy: a case-control study. J Neurol. 1985;232(6): 363-365.
15. Rath B, Linder T, Cornblath D, et al. All that palsies is not Bell's-the need to define Bell's palsy as an adverse event following immunization. Vaccine. 2007;26(1):1-14.
16. Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med. 2004;350(9):896-903.
17. ZhouW, Pool V, DeStefano F, et al. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Pharmacoepidemiol Drug Saf. 2004; 13(8):505-510.
18. Greene SK, Kulldorff M, Lewis EM, et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010; 171(2):177-188.
19. Stowe J, Andrews N, Wise L, et al. Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccin. 2006;2(3):110-112.
20. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703-710.
21. Fireman B, Lee J, Lewis N, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656.
22. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubellavaricella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1-e8.
23. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010;28(45):7267-7272.
24. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25(10):1768-1797.